Thaddeus P. Dryja

Harvard University

Election Year: 1996
Primary Section: 41, Medical Genetics, Hematology, and Oncology
Membership Type: Member


Thaddeus (Ted) Dryja received his B.A. from Yale College in chemistry and his M.D. from Yale University School of Medicine. From 1977-1983, he did an ophthalmology residency as well as fellowships in ophthalmic pathology and in molecular genetics at Harvard Medical School. In 1983 he joined the faculty at Harvard Medical School and the staff at the Massachusetts Eye and Ear Infirmary in Boston. He became a professor of ophthalmology in 1992 and the David G. Cogan Professor of Ophthalmology in 1993. At the Infirmary, he had a practice in general ophthalmology and in ophthalmic pathology. He also headed a research lab that studied the molecular genetics of hereditary diseases of the retina. Major accomplishments from his research laboratory included obtaining compelling evidence for the recessive nature of oncogenic mutations at tumor suppressor genes, the cloning of the retinoblastoma gene, and the identification of 16 different genes responsible for forms of retinitis pigmentosa and stationary night blindness. Dr. Dryja joined the Novartis Institutes for Biomedical Research (NIBR) in 2006 as the head of Translational Medicine in Ophthalmology. From 2009-2017, he was head of ophthalmology research at NIBR. In 2017 he moved back to Harvard Medical School and Massachusetts Eye and Ear Infirmary to work part-time in the eye pathology department.

Research Interests

Search for novel biochemical pathways and disease mechanisms that can lead to the discovery of therapies for ocular diseases, especially age-related macular degeneration, diabetic retinopathy, glaucoma, retinitis pigmentosa, uveitis, and dry eye.

Powered by Blackbaud
nonprofit software